Beauty product-related exposures and childhood brain tumors in seven countries : results from the SEARCH international brain tumor study
Identifieur interne : 004888 ( PascalFrancis/Corpus ); précédent : 004887; suivant : 004889Beauty product-related exposures and childhood brain tumors in seven countries : results from the SEARCH international brain tumor study
Auteurs : J. T. Efird ; E. A. Holly ; S. Cordier ; B. A. Mueller ; F. Lubin ; G. Filippini ; R. Peris-Bonet ; M. Mccredie ; A. Arslan ; P. Bracci ; S. Preston-MartinSource :
- Journal of neuro-oncology [ 0167-594X ] ; 2005.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
Abstract
Data from 1218 cases of childhood brain tumors (CBT) diagnosed between 1976 and 1994 and 2223 matched controls from the general population were included in an analysis of maternal beauty product exposure and beauty-related employment in 9 centers in 7 countries. A 50% increased odds ratio (OR) [95% confidence interval (CI) = 1.0-2.1] for CBT was observed among children of mothers who were exposed via personal use of and/or possible ambient contact with beauty products during the 5 years preceding the index child's birth compared with children of mothers never exposed to beauty products during this time period. Overall maternal personal use of hair-coloring agents in the month before or during the pregnancy of the index child's birth was not associated with CBT (OR = 1.0, CI = 0.83-1.3) or with astroglial (OR = 1.1, CI = 0.85-1.4), PNET (OR = 1.0, CI = 0.71-1.5) and other glial subtypes (OR = 1.0, CI = 0.62-1.0 ). Similarly, no statistically increased ORs or discernable pattern of risk estimates were observed for period of use or for number of applications per year for maternal personal use of hair-coloring agents overall or by histologic type. Among children born on or after 1980, increased ORs for CBT were associated with maternal non-work-related exposure to any beauty products (OR = 2.6, CI = 1.2-5.9), hair dyes (OR = 11, CI = 1.2-90), and hair sprays (OR = 3.4, CI = 1.0-11). No overall increased OR for CBT was observed among children of mothers employed in beauty-related jobs during the 5 years preceding the index child's birth compared with those who reported no beauty-related employment. In general, other specific beauty product-related exposures were not associated with increased ORs for CBT. Data from our study provide little evidence of an increased risk for CBT with mothers' exposures to beauty products.
Notice en format standard (ISO 2709)
Pour connaître la documentation sur le format Inist Standard.
| pA |
|
|---|
Format Inist (serveur)
| NO : | PASCAL 05-0305177 INIST |
|---|---|
| ET : | Beauty product-related exposures and childhood brain tumors in seven countries : results from the SEARCH international brain tumor study |
| AU : | EFIRD (J. T.); HOLLY (E. A.); CORDIER (S.); MUELLER (B. A.); LUBIN (F.); FILIPPINI (G.); PERIS-BONET (R.); MCCREDIE (M.); ARSLAN (A.); BRACCI (P.); PRESTON-MARTIN (S.) |
| AF : | John A. Burns School of Medicine, University of Hawaii/Honolulu, Hawaii at Manoa/Etats-Unis (1 aut.); Department of Epidemiology and Biostatistics, University of California/San Francisco, California/Etats-Unis (1 aut., 2 aut., 10 aut.); Department of Health Research and Policy, Stanford University School of Medicine/Stanford, CA/Etats-Unis (2 aut.); INSERM U435/Rennes/France (3 aut.); Fred Hutchison Cancer Research Center/Seattle, Washington/Etats-Unis (4 aut.); Cancer Epidemiology Unit, Gertner Institute, Chaim Sheba Medical Center, Sackler School of Medicine/Tel-Hashomer/Israël (5 aut.); Neuroepidemiology Research Unit, National Neurological Institute 'C Besta'/Milan/Italie (6 aut.); Registro Nacional de Tumores Infantiles, Instituto Lopez Pinero, CSlC-Universitat de Valencia/Valencia/Espagne (7 aut.); Department of Preventive and Social Medicine, University of Otago/Dunedin/Nouvelle-Zélande (8 aut.); Previously Epidemiology Research Unit, New South Wales Cancer Council/Sydney/Australie (8 aut.); International Agency for Research on Cancer/Lyon/France (9 aut.); Department of Preventive Medicine, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California/Los Angeles, California/Etats-Unis (11 aut.) |
| DT : | Publication en série; Etude de cas, cas et faits cliniques; Niveau analytique |
| SO : | Journal of neuro-oncology; ISSN 0167-594X; Pays-Bas; Da. 2005; Vol. 72; No. 2; Pp. 133-147; Bibl. 150 ref. |
| LA : | Anglais |
| EA : | Data from 1218 cases of childhood brain tumors (CBT) diagnosed between 1976 and 1994 and 2223 matched controls from the general population were included in an analysis of maternal beauty product exposure and beauty-related employment in 9 centers in 7 countries. A 50% increased odds ratio (OR) [95% confidence interval (CI) = 1.0-2.1] for CBT was observed among children of mothers who were exposed via personal use of and/or possible ambient contact with beauty products during the 5 years preceding the index child's birth compared with children of mothers never exposed to beauty products during this time period. Overall maternal personal use of hair-coloring agents in the month before or during the pregnancy of the index child's birth was not associated with CBT (OR = 1.0, CI = 0.83-1.3) or with astroglial (OR = 1.1, CI = 0.85-1.4), PNET (OR = 1.0, CI = 0.71-1.5) and other glial subtypes (OR = 1.0, CI = 0.62-1.0 ). Similarly, no statistically increased ORs or discernable pattern of risk estimates were observed for period of use or for number of applications per year for maternal personal use of hair-coloring agents overall or by histologic type. Among children born on or after 1980, increased ORs for CBT were associated with maternal non-work-related exposure to any beauty products (OR = 2.6, CI = 1.2-5.9), hair dyes (OR = 11, CI = 1.2-90), and hair sprays (OR = 3.4, CI = 1.0-11). No overall increased OR for CBT was observed among children of mothers employed in beauty-related jobs during the 5 years preceding the index child's birth compared with those who reported no beauty-related employment. In general, other specific beauty product-related exposures were not associated with increased ORs for CBT. Data from our study provide little evidence of an increased risk for CBT with mothers' exposures to beauty products. |
| CC : | 002B17; 002B05C02D; 002A25B |
| FD : | Système nerveux pathologie; Tumeur intracrânienne; Enfant; Face; Cheveu; Poil; Couleur; Embrun |
| FG : | Homme; Encéphale pathologie; Système nerveux central pathologie |
| ED : | Nervous system diseases; Intracranial tumor; Child; Face; Hair (head); Hair; Color; Spray |
| EG : | Human; Cerebral disorder; Central nervous system disease |
| SD : | Sistema nervioso patología; Tumor intracraneal; Niño; Cara; Cabello; Pelo; Color; Brumazón |
| LO : | INIST-20812.354000138153380070 |
| ID : | 05-0305177 |
Links to Exploration step
Pascal:05-0305177Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Beauty product-related exposures and childhood brain tumors in seven countries : results from the SEARCH international brain tumor study</title><author><name sortKey="Efird, J T" sort="Efird, J T" uniqKey="Efird J" first="J. T." last="Efird">J. T. Efird</name><affiliation><inist:fA14 i1="01"><s1>John A. Burns School of Medicine, University of Hawaii</s1><s2>Honolulu, Hawaii at Manoa</s2><s3>USA</s3><sZ>1 aut.</sZ></inist:fA14></affiliation><affiliation><inist:fA14 i1="02"><s1>Department of Epidemiology and Biostatistics, University of California</s1><s2>San Francisco, California</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>10 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Holly, E A" sort="Holly, E A" uniqKey="Holly E" first="E. A." last="Holly">E. A. Holly</name><affiliation><inist:fA14 i1="02"><s1>Department of Epidemiology and Biostatistics, University of California</s1><s2>San Francisco, California</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>10 aut.</sZ></inist:fA14></affiliation><affiliation><inist:fA14 i1="03"><s1>Department of Health Research and Policy, Stanford University School of Medicine</s1><s2>Stanford, CA</s2><s3>USA</s3><sZ>2 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Cordier, S" sort="Cordier, S" uniqKey="Cordier S" first="S." last="Cordier">S. Cordier</name><affiliation><inist:fA14 i1="04"><s1>INSERM U435</s1><s2>Rennes</s2><s3>FRA</s3><sZ>3 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Mueller, B A" sort="Mueller, B A" uniqKey="Mueller B" first="B. A." last="Mueller">B. A. Mueller</name><affiliation><inist:fA14 i1="05"><s1>Fred Hutchison Cancer Research Center</s1><s2>Seattle, Washington</s2><s3>USA</s3><sZ>4 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Lubin, F" sort="Lubin, F" uniqKey="Lubin F" first="F." last="Lubin">F. Lubin</name><affiliation><inist:fA14 i1="06"><s1>Cancer Epidemiology Unit, Gertner Institute, Chaim Sheba Medical Center, Sackler School of Medicine</s1><s2>Tel-Hashomer</s2><s3>ISR</s3><sZ>5 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Filippini, G" sort="Filippini, G" uniqKey="Filippini G" first="G." last="Filippini">G. Filippini</name><affiliation><inist:fA14 i1="07"><s1>Neuroepidemiology Research Unit, National Neurological Institute 'C Besta'</s1><s2>Milan</s2><s3>ITA</s3><sZ>6 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Peris Bonet, R" sort="Peris Bonet, R" uniqKey="Peris Bonet R" first="R." last="Peris-Bonet">R. Peris-Bonet</name><affiliation><inist:fA14 i1="08"><s1>Registro Nacional de Tumores Infantiles, Instituto Lopez Pinero, CSlC-Universitat de Valencia</s1><s2>Valencia</s2><s3>ESP</s3><sZ>7 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Mccredie, M" sort="Mccredie, M" uniqKey="Mccredie M" first="M." last="Mccredie">M. Mccredie</name><affiliation><inist:fA14 i1="09"><s1>Department of Preventive and Social Medicine, University of Otago</s1><s2>Dunedin</s2><s3>NZL</s3><sZ>8 aut.</sZ></inist:fA14></affiliation><affiliation><inist:fA14 i1="10"><s1>Previously Epidemiology Research Unit, New South Wales Cancer Council</s1><s2>Sydney</s2><s3>AUS</s3><sZ>8 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Arslan, A" sort="Arslan, A" uniqKey="Arslan A" first="A." last="Arslan">A. Arslan</name><affiliation><inist:fA14 i1="11"><s1>International Agency for Research on Cancer</s1><s2>Lyon</s2><s3>FRA</s3><sZ>9 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Bracci, P" sort="Bracci, P" uniqKey="Bracci P" first="P." last="Bracci">P. Bracci</name><affiliation><inist:fA14 i1="02"><s1>Department of Epidemiology and Biostatistics, University of California</s1><s2>San Francisco, California</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>10 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Preston Martin, S" sort="Preston Martin, S" uniqKey="Preston Martin S" first="S." last="Preston-Martin">S. Preston-Martin</name><affiliation><inist:fA14 i1="12"><s1>Department of Preventive Medicine, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California</s1><s2>Los Angeles, California</s2><s3>USA</s3><sZ>11 aut.</sZ></inist:fA14></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">INIST</idno><idno type="inist">05-0305177</idno><date when="2005">2005</date><idno type="stanalyst">PASCAL 05-0305177 INIST</idno><idno type="RBID">Pascal:05-0305177</idno><idno type="wicri:Area/PascalFrancis/Corpus">004888</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Beauty product-related exposures and childhood brain tumors in seven countries : results from the SEARCH international brain tumor study</title><author><name sortKey="Efird, J T" sort="Efird, J T" uniqKey="Efird J" first="J. T." last="Efird">J. T. Efird</name><affiliation><inist:fA14 i1="01"><s1>John A. Burns School of Medicine, University of Hawaii</s1><s2>Honolulu, Hawaii at Manoa</s2><s3>USA</s3><sZ>1 aut.</sZ></inist:fA14></affiliation><affiliation><inist:fA14 i1="02"><s1>Department of Epidemiology and Biostatistics, University of California</s1><s2>San Francisco, California</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>10 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Holly, E A" sort="Holly, E A" uniqKey="Holly E" first="E. A." last="Holly">E. A. Holly</name><affiliation><inist:fA14 i1="02"><s1>Department of Epidemiology and Biostatistics, University of California</s1><s2>San Francisco, California</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>10 aut.</sZ></inist:fA14></affiliation><affiliation><inist:fA14 i1="03"><s1>Department of Health Research and Policy, Stanford University School of Medicine</s1><s2>Stanford, CA</s2><s3>USA</s3><sZ>2 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Cordier, S" sort="Cordier, S" uniqKey="Cordier S" first="S." last="Cordier">S. Cordier</name><affiliation><inist:fA14 i1="04"><s1>INSERM U435</s1><s2>Rennes</s2><s3>FRA</s3><sZ>3 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Mueller, B A" sort="Mueller, B A" uniqKey="Mueller B" first="B. A." last="Mueller">B. A. Mueller</name><affiliation><inist:fA14 i1="05"><s1>Fred Hutchison Cancer Research Center</s1><s2>Seattle, Washington</s2><s3>USA</s3><sZ>4 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Lubin, F" sort="Lubin, F" uniqKey="Lubin F" first="F." last="Lubin">F. Lubin</name><affiliation><inist:fA14 i1="06"><s1>Cancer Epidemiology Unit, Gertner Institute, Chaim Sheba Medical Center, Sackler School of Medicine</s1><s2>Tel-Hashomer</s2><s3>ISR</s3><sZ>5 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Filippini, G" sort="Filippini, G" uniqKey="Filippini G" first="G." last="Filippini">G. Filippini</name><affiliation><inist:fA14 i1="07"><s1>Neuroepidemiology Research Unit, National Neurological Institute 'C Besta'</s1><s2>Milan</s2><s3>ITA</s3><sZ>6 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Peris Bonet, R" sort="Peris Bonet, R" uniqKey="Peris Bonet R" first="R." last="Peris-Bonet">R. Peris-Bonet</name><affiliation><inist:fA14 i1="08"><s1>Registro Nacional de Tumores Infantiles, Instituto Lopez Pinero, CSlC-Universitat de Valencia</s1><s2>Valencia</s2><s3>ESP</s3><sZ>7 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Mccredie, M" sort="Mccredie, M" uniqKey="Mccredie M" first="M." last="Mccredie">M. Mccredie</name><affiliation><inist:fA14 i1="09"><s1>Department of Preventive and Social Medicine, University of Otago</s1><s2>Dunedin</s2><s3>NZL</s3><sZ>8 aut.</sZ></inist:fA14></affiliation><affiliation><inist:fA14 i1="10"><s1>Previously Epidemiology Research Unit, New South Wales Cancer Council</s1><s2>Sydney</s2><s3>AUS</s3><sZ>8 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Arslan, A" sort="Arslan, A" uniqKey="Arslan A" first="A." last="Arslan">A. Arslan</name><affiliation><inist:fA14 i1="11"><s1>International Agency for Research on Cancer</s1><s2>Lyon</s2><s3>FRA</s3><sZ>9 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Bracci, P" sort="Bracci, P" uniqKey="Bracci P" first="P." last="Bracci">P. Bracci</name><affiliation><inist:fA14 i1="02"><s1>Department of Epidemiology and Biostatistics, University of California</s1><s2>San Francisco, California</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>10 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Preston Martin, S" sort="Preston Martin, S" uniqKey="Preston Martin S" first="S." last="Preston-Martin">S. Preston-Martin</name><affiliation><inist:fA14 i1="12"><s1>Department of Preventive Medicine, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California</s1><s2>Los Angeles, California</s2><s3>USA</s3><sZ>11 aut.</sZ></inist:fA14></affiliation></author></analytic><series><title level="j" type="main">Journal of neuro-oncology</title><title level="j" type="abbreviated">J. neuro-oncol.</title><idno type="ISSN">0167-594X</idno><imprint><date when="2005">2005</date></imprint></series></biblStruct></sourceDesc><seriesStmt><title level="j" type="main">Journal of neuro-oncology</title><title level="j" type="abbreviated">J. neuro-oncol.</title><idno type="ISSN">0167-594X</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Child</term><term>Color</term><term>Face</term><term>Hair</term><term>Hair (head)</term><term>Intracranial tumor</term><term>Nervous system diseases</term><term>Spray</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Système nerveux pathologie</term><term>Tumeur intracrânienne</term><term>Enfant</term><term>Face</term><term>Cheveu</term><term>Poil</term><term>Couleur</term><term>Embrun</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Data from 1218 cases of childhood brain tumors (CBT) diagnosed between 1976 and 1994 and 2223 matched controls from the general population were included in an analysis of maternal beauty product exposure and beauty-related employment in 9 centers in 7 countries. A 50% increased odds ratio (OR) [95% confidence interval (CI) = 1.0-2.1] for CBT was observed among children of mothers who were exposed via personal use of and/or possible ambient contact with beauty products during the 5 years preceding the index child's birth compared with children of mothers never exposed to beauty products during this time period. Overall maternal personal use of hair-coloring agents in the month before or during the pregnancy of the index child's birth was not associated with CBT (OR = 1.0, CI = 0.83-1.3) or with astroglial (OR = 1.1, CI = 0.85-1.4), PNET (OR = 1.0, CI = 0.71-1.5) and other glial subtypes (OR = 1.0, CI = 0.62-1.0 ). Similarly, no statistically increased ORs or discernable pattern of risk estimates were observed for period of use or for number of applications per year for maternal personal use of hair-coloring agents overall or by histologic type. Among children born on or after 1980, increased ORs for CBT were associated with maternal non-work-related exposure to any beauty products (OR = 2.6, CI = 1.2-5.9), hair dyes (OR = 11, CI = 1.2-90), and hair sprays (OR = 3.4, CI = 1.0-11). No overall increased OR for CBT was observed among children of mothers employed in beauty-related jobs during the 5 years preceding the index child's birth compared with those who reported no beauty-related employment. In general, other specific beauty product-related exposures were not associated with increased ORs for CBT. Data from our study provide little evidence of an increased risk for CBT with mothers' exposures to beauty products.</div></front></TEI><inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0167-594X</s0></fA01><fA03 i2="1"><s0>J. neuro-oncol.</s0></fA03><fA05><s2>72</s2></fA05><fA06><s2>2</s2></fA06><fA08 i1="01" i2="1" l="ENG"><s1>Beauty product-related exposures and childhood brain tumors in seven countries : results from the SEARCH international brain tumor study</s1></fA08><fA11 i1="01" i2="1"><s1>EFIRD (J. T.)</s1></fA11><fA11 i1="02" i2="1"><s1>HOLLY (E. A.)</s1></fA11><fA11 i1="03" i2="1"><s1>CORDIER (S.)</s1></fA11><fA11 i1="04" i2="1"><s1>MUELLER (B. A.)</s1></fA11><fA11 i1="05" i2="1"><s1>LUBIN (F.)</s1></fA11><fA11 i1="06" i2="1"><s1>FILIPPINI (G.)</s1></fA11><fA11 i1="07" i2="1"><s1>PERIS-BONET (R.)</s1></fA11><fA11 i1="08" i2="1"><s1>MCCREDIE (M.)</s1></fA11><fA11 i1="09" i2="1"><s1>ARSLAN (A.)</s1></fA11><fA11 i1="10" i2="1"><s1>BRACCI (P.)</s1></fA11><fA11 i1="11" i2="1"><s1>PRESTON-MARTIN (S.)</s1></fA11><fA14 i1="01"><s1>John A. Burns School of Medicine, University of Hawaii</s1><s2>Honolulu, Hawaii at Manoa</s2><s3>USA</s3><sZ>1 aut.</sZ></fA14><fA14 i1="02"><s1>Department of Epidemiology and Biostatistics, University of California</s1><s2>San Francisco, California</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>10 aut.</sZ></fA14><fA14 i1="03"><s1>Department of Health Research and Policy, Stanford University School of Medicine</s1><s2>Stanford, CA</s2><s3>USA</s3><sZ>2 aut.</sZ></fA14><fA14 i1="04"><s1>INSERM U435</s1><s2>Rennes</s2><s3>FRA</s3><sZ>3 aut.</sZ></fA14><fA14 i1="05"><s1>Fred Hutchison Cancer Research Center</s1><s2>Seattle, Washington</s2><s3>USA</s3><sZ>4 aut.</sZ></fA14><fA14 i1="06"><s1>Cancer Epidemiology Unit, Gertner Institute, Chaim Sheba Medical Center, Sackler School of Medicine</s1><s2>Tel-Hashomer</s2><s3>ISR</s3><sZ>5 aut.</sZ></fA14><fA14 i1="07"><s1>Neuroepidemiology Research Unit, National Neurological Institute 'C Besta'</s1><s2>Milan</s2><s3>ITA</s3><sZ>6 aut.</sZ></fA14><fA14 i1="08"><s1>Registro Nacional de Tumores Infantiles, Instituto Lopez Pinero, CSlC-Universitat de Valencia</s1><s2>Valencia</s2><s3>ESP</s3><sZ>7 aut.</sZ></fA14><fA14 i1="09"><s1>Department of Preventive and Social Medicine, University of Otago</s1><s2>Dunedin</s2><s3>NZL</s3><sZ>8 aut.</sZ></fA14><fA14 i1="10"><s1>Previously Epidemiology Research Unit, New South Wales Cancer Council</s1><s2>Sydney</s2><s3>AUS</s3><sZ>8 aut.</sZ></fA14><fA14 i1="11"><s1>International Agency for Research on Cancer</s1><s2>Lyon</s2><s3>FRA</s3><sZ>9 aut.</sZ></fA14><fA14 i1="12"><s1>Department of Preventive Medicine, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California</s1><s2>Los Angeles, California</s2><s3>USA</s3><sZ>11 aut.</sZ></fA14><fA20><s1>133-147</s1></fA20><fA21><s1>2005</s1></fA21><fA23 i1="01"><s0>ENG</s0></fA23><fA43 i1="01"><s1>INIST</s1><s2>20812</s2><s5>354000138153380070</s5></fA43><fA44><s0>0000</s0><s1>© 2005 INIST-CNRS. All rights reserved.</s1></fA44><fA45><s0>150 ref.</s0></fA45><fA47 i1="01" i2="1"><s0>05-0305177</s0></fA47><fA60><s1>P</s1><s3>EC</s3></fA60><fA61><s0>A</s0></fA61><fA64 i1="01" i2="1"><s0>Journal of neuro-oncology</s0></fA64><fA66 i1="01"><s0>NLD</s0></fA66><fC01 i1="01" l="ENG"><s0>Data from 1218 cases of childhood brain tumors (CBT) diagnosed between 1976 and 1994 and 2223 matched controls from the general population were included in an analysis of maternal beauty product exposure and beauty-related employment in 9 centers in 7 countries. A 50% increased odds ratio (OR) [95% confidence interval (CI) = 1.0-2.1] for CBT was observed among children of mothers who were exposed via personal use of and/or possible ambient contact with beauty products during the 5 years preceding the index child's birth compared with children of mothers never exposed to beauty products during this time period. Overall maternal personal use of hair-coloring agents in the month before or during the pregnancy of the index child's birth was not associated with CBT (OR = 1.0, CI = 0.83-1.3) or with astroglial (OR = 1.1, CI = 0.85-1.4), PNET (OR = 1.0, CI = 0.71-1.5) and other glial subtypes (OR = 1.0, CI = 0.62-1.0 ). Similarly, no statistically increased ORs or discernable pattern of risk estimates were observed for period of use or for number of applications per year for maternal personal use of hair-coloring agents overall or by histologic type. Among children born on or after 1980, increased ORs for CBT were associated with maternal non-work-related exposure to any beauty products (OR = 2.6, CI = 1.2-5.9), hair dyes (OR = 11, CI = 1.2-90), and hair sprays (OR = 3.4, CI = 1.0-11). No overall increased OR for CBT was observed among children of mothers employed in beauty-related jobs during the 5 years preceding the index child's birth compared with those who reported no beauty-related employment. In general, other specific beauty product-related exposures were not associated with increased ORs for CBT. Data from our study provide little evidence of an increased risk for CBT with mothers' exposures to beauty products.</s0></fC01><fC02 i1="01" i2="X"><s0>002B17</s0></fC02><fC02 i1="02" i2="X"><s0>002B05C02D</s0></fC02><fC02 i1="03" i2="X"><s0>002A25B</s0></fC02><fC03 i1="01" i2="X" l="FRE"><s0>Système nerveux pathologie</s0><s5>01</s5></fC03><fC03 i1="01" i2="X" l="ENG"><s0>Nervous system diseases</s0><s5>01</s5></fC03><fC03 i1="01" i2="X" l="SPA"><s0>Sistema nervioso patología</s0><s5>01</s5></fC03><fC03 i1="02" i2="X" l="FRE"><s0>Tumeur intracrânienne</s0><s2>NM</s2><s5>02</s5></fC03><fC03 i1="02" i2="X" l="ENG"><s0>Intracranial tumor</s0><s2>NM</s2><s5>02</s5></fC03><fC03 i1="02" i2="X" l="SPA"><s0>Tumor intracraneal</s0><s2>NM</s2><s5>02</s5></fC03><fC03 i1="03" i2="X" l="FRE"><s0>Enfant</s0><s5>09</s5></fC03><fC03 i1="03" i2="X" l="ENG"><s0>Child</s0><s5>09</s5></fC03><fC03 i1="03" i2="X" l="SPA"><s0>Niño</s0><s5>09</s5></fC03><fC03 i1="04" i2="X" l="FRE"><s0>Face</s0><s5>10</s5></fC03><fC03 i1="04" i2="X" l="ENG"><s0>Face</s0><s5>10</s5></fC03><fC03 i1="04" i2="X" l="SPA"><s0>Cara</s0><s5>10</s5></fC03><fC03 i1="05" i2="X" l="FRE"><s0>Cheveu</s0><s5>11</s5></fC03><fC03 i1="05" i2="X" l="ENG"><s0>Hair (head)</s0><s5>11</s5></fC03><fC03 i1="05" i2="X" l="SPA"><s0>Cabello</s0><s5>11</s5></fC03><fC03 i1="06" i2="X" l="FRE"><s0>Poil</s0><s5>12</s5></fC03><fC03 i1="06" i2="X" l="ENG"><s0>Hair</s0><s5>12</s5></fC03><fC03 i1="06" i2="X" l="SPA"><s0>Pelo</s0><s5>12</s5></fC03><fC03 i1="07" i2="X" l="FRE"><s0>Couleur</s0><s5>13</s5></fC03><fC03 i1="07" i2="X" l="ENG"><s0>Color</s0><s5>13</s5></fC03><fC03 i1="07" i2="X" l="SPA"><s0>Color</s0><s5>13</s5></fC03><fC03 i1="08" i2="X" l="FRE"><s0>Embrun</s0><s5>14</s5></fC03><fC03 i1="08" i2="X" l="ENG"><s0>Spray</s0><s5>14</s5></fC03><fC03 i1="08" i2="X" l="SPA"><s0>Brumazón</s0><s5>14</s5></fC03><fC07 i1="01" i2="X" l="FRE"><s0>Homme</s0></fC07><fC07 i1="01" i2="X" l="ENG"><s0>Human</s0></fC07><fC07 i1="01" i2="X" l="SPA"><s0>Hombre</s0></fC07><fC07 i1="02" i2="X" l="FRE"><s0>Encéphale pathologie</s0><s5>37</s5></fC07><fC07 i1="02" i2="X" l="ENG"><s0>Cerebral disorder</s0><s5>37</s5></fC07><fC07 i1="02" i2="X" l="SPA"><s0>Encéfalo patología</s0><s5>37</s5></fC07><fC07 i1="03" i2="X" l="FRE"><s0>Système nerveux central pathologie</s0><s5>38</s5></fC07><fC07 i1="03" i2="X" l="ENG"><s0>Central nervous system disease</s0><s5>38</s5></fC07><fC07 i1="03" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0><s5>38</s5></fC07><fN21><s1>213</s1></fN21><fN44 i1="01"><s1>OTO</s1></fN44><fN82><s1>OTO</s1></fN82></pA></standard><server><NO>PASCAL 05-0305177 INIST</NO><ET>Beauty product-related exposures and childhood brain tumors in seven countries : results from the SEARCH international brain tumor study</ET><AU>EFIRD (J. T.); HOLLY (E. A.); CORDIER (S.); MUELLER (B. A.); LUBIN (F.); FILIPPINI (G.); PERIS-BONET (R.); MCCREDIE (M.); ARSLAN (A.); BRACCI (P.); PRESTON-MARTIN (S.)</AU><AF>John A. Burns School of Medicine, University of Hawaii/Honolulu, Hawaii at Manoa/Etats-Unis (1 aut.); Department of Epidemiology and Biostatistics, University of California/San Francisco, California/Etats-Unis (1 aut., 2 aut., 10 aut.); Department of Health Research and Policy, Stanford University School of Medicine/Stanford, CA/Etats-Unis (2 aut.); INSERM U435/Rennes/France (3 aut.); Fred Hutchison Cancer Research Center/Seattle, Washington/Etats-Unis (4 aut.); Cancer Epidemiology Unit, Gertner Institute, Chaim Sheba Medical Center, Sackler School of Medicine/Tel-Hashomer/Israël (5 aut.); Neuroepidemiology Research Unit, National Neurological Institute 'C Besta'/Milan/Italie (6 aut.); Registro Nacional de Tumores Infantiles, Instituto Lopez Pinero, CSlC-Universitat de Valencia/Valencia/Espagne (7 aut.); Department of Preventive and Social Medicine, University of Otago/Dunedin/Nouvelle-Zélande (8 aut.); Previously Epidemiology Research Unit, New South Wales Cancer Council/Sydney/Australie (8 aut.); International Agency for Research on Cancer/Lyon/France (9 aut.); Department of Preventive Medicine, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California/Los Angeles, California/Etats-Unis (11 aut.)</AF><DT>Publication en série; Etude de cas, cas et faits cliniques; Niveau analytique</DT><SO>Journal of neuro-oncology; ISSN 0167-594X; Pays-Bas; Da. 2005; Vol. 72; No. 2; Pp. 133-147; Bibl. 150 ref.</SO><LA>Anglais</LA><EA>Data from 1218 cases of childhood brain tumors (CBT) diagnosed between 1976 and 1994 and 2223 matched controls from the general population were included in an analysis of maternal beauty product exposure and beauty-related employment in 9 centers in 7 countries. A 50% increased odds ratio (OR) [95% confidence interval (CI) = 1.0-2.1] for CBT was observed among children of mothers who were exposed via personal use of and/or possible ambient contact with beauty products during the 5 years preceding the index child's birth compared with children of mothers never exposed to beauty products during this time period. Overall maternal personal use of hair-coloring agents in the month before or during the pregnancy of the index child's birth was not associated with CBT (OR = 1.0, CI = 0.83-1.3) or with astroglial (OR = 1.1, CI = 0.85-1.4), PNET (OR = 1.0, CI = 0.71-1.5) and other glial subtypes (OR = 1.0, CI = 0.62-1.0 ). Similarly, no statistically increased ORs or discernable pattern of risk estimates were observed for period of use or for number of applications per year for maternal personal use of hair-coloring agents overall or by histologic type. Among children born on or after 1980, increased ORs for CBT were associated with maternal non-work-related exposure to any beauty products (OR = 2.6, CI = 1.2-5.9), hair dyes (OR = 11, CI = 1.2-90), and hair sprays (OR = 3.4, CI = 1.0-11). No overall increased OR for CBT was observed among children of mothers employed in beauty-related jobs during the 5 years preceding the index child's birth compared with those who reported no beauty-related employment. In general, other specific beauty product-related exposures were not associated with increased ORs for CBT. Data from our study provide little evidence of an increased risk for CBT with mothers' exposures to beauty products.</EA><CC>002B17; 002B05C02D; 002A25B</CC><FD>Système nerveux pathologie; Tumeur intracrânienne; Enfant; Face; Cheveu; Poil; Couleur; Embrun</FD><FG>Homme; Encéphale pathologie; Système nerveux central pathologie</FG><ED>Nervous system diseases; Intracranial tumor; Child; Face; Hair (head); Hair; Color; Spray</ED><EG>Human; Cerebral disorder; Central nervous system disease</EG><SD>Sistema nervioso patología; Tumor intracraneal; Niño; Cara; Cabello; Pelo; Color; Brumazón</SD><LO>INIST-20812.354000138153380070</LO><ID>05-0305177</ID></server></inist></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004888 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 004888 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= PascalFrancis
|étape= Corpus
|type= RBID
|clé= Pascal:05-0305177
|texte= Beauty product-related exposures and childhood brain tumors in seven countries : results from the SEARCH international brain tumor study
}}
| This area was generated with Dilib version V0.6.33. |  |